A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function

Summary

Microvascular dysfunction is a key determinant of pathogenesis and outcome in patients suffering an acute myocardial infarction. The investigators hypothesise that treatment with intracoronary abciximab, a potent anti platelet agent, at the time of coronary stent insertion, will improve microvascular function.

Timeline

Start

2012-02

Primary completion

2014-06

Completion

2014-06

Drugs

Indications